MedPath

Prevention Program of Diabetes in São Paulo

Not Applicable
Conditions
Individuals with prediabetes (impaired glucose tolerance or impaired fasting glycemia)or metabolic syndrome without diabetes.
C18.452.394.750.149
D09.546.359.448.500
Registration Number
RBR-65n292
Lead Sponsor
Faculdade de Saúde Pública, USP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Individuals with prediabetes (impaired fasting glycemia: fasting glycemia between 100 and 125 mg/dL; impaired glucose tolerance: 2-hour glucose between 140 and 200 mg/dL) or fulfilling metabolic syndrome criteria according to the International Diabetes Federation for Latin-American populations.

Exclusion Criteria

Medical history of neurological or psychiatric disturbances, thyroid, liver, renal and infectious diseases.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
. reduction of fasting and post-load glycemia<br>. blood pressure reduction<br>. lipid profile improvement<br><br>Outcomes reported were influenced by interventions once they resulted in dietary habits and physical activity improvement.<br>Outcomes were analyzed at 9 and 18 months after baseline evaluation.;Results:<br>After 9 months of interventions, greater reductions were found in fasting and pos-load glycemia and blood pressure in interdisciplinary intervention group, compared with traditional. At 18-month follow-up, the interdisciplinary intervention group maintained lower blood pressure levels.
Secondary Outcome Measures
NameTimeMethod
. conversion rate to diabetes<br><br>Outcomes reported were influenced by interventions once they resulted in dietary habits and physical activity improvement.<br>Outcomes were analyzed at 9 and 18 months after baseline evaluation.;Results:<br>The number of new cases of diabetes did not differ between interdisciplinary and traditional intervention groups at 9 and 18 months.
© Copyright 2025. All Rights Reserved by MedPath